Panagora Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Panagora Asset Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-140,847	Closed	-$330K	–	2566
2018 Q2	$330K	Buy	140,847 +2,139	+2%	+$5.97K	﹤0.01%	1496
2018 Q1	$408K	Buy	138,708 +42,917	+45%	+$117K	﹤0.01%	1452
2017 Q4	$262K	Buy	+95,791	New	+$294K	﹤0.01%	1581
2017 Q3	–	Sell	-4,366	Closed	-$11K	–	2677
2017 Q2	$11K	Sell	4,366 -5,840	-57%	-$13.4K	﹤0.01%	2379
2017 Q1	$23K	Sell	10,206 -335,807	-97%	-$743K	﹤0.01%	2154
2016 Q4	$734K	Buy	+346,013	New	+$965K	﹤0.01%	1320
2015 Q1	–	Sell	-82,829	Closed	-$639K	–	2476
2014 Q4	$639K	Sell	82,829 -143,875	-63%	-$1.14M	﹤0.01%	1190
2014 Q3	$1.69M	Sell	226,704 -15,766	-7%	-$146K	0.01%	816
2014 Q2	$2.35M	Sell	242,470 -355,019	-59%	-$3.16M	0.01%	760
2014 Q1	$4.96M	Buy	597,489 +104,132	+21%	+$893K	0.02%	550
2013 Q4	$4.16M	Buy	493,357 +40,283	+9%	+$339K	0.02%	586
2013 Q3	$3.61M	Sell	453,074 -14,824	-3%	-$119K	0.02%	607
2013 Q2	$3.61M	Buy	+467,898	New	+$3.65M	0.02%	556

Other funds holding PDLI

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Panagora Asset Management's PDLI Position: Q3 2018 in Review

Panagora Asset Management sold out of PDL BioPharma, Inc. (PDLI) in Q3 2018, closing a stake of 140,847 shares — an estimated $330K sold.

Panagora Asset Management first reported a position in PDLI in Q2 2013 and held it in 13 quarters. The position peaked at $4.96M in Q1 2014. 152 funds tracked by Wall St. Rank hold PDLI as of Q3 2018.

Panagora Asset Management reported no remaining PDL BioPharma, Inc. position as of Q3 2018 after selling out during the quarter.
Panagora Asset Management sold 140,847 PDL BioPharma, Inc. shares in Q3 2018, an estimated $330K.
Panagora Asset Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 13 quarters.
Panagora Asset Management's PDL BioPharma, Inc. position peaked at $4.96M in Q1 2014.
152 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2018.

Based on Panagora Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.